Table 1.
Clinicopathological characteristics of the glioma patients
| Characteristics | No. of patients (%) |
|---|---|
| Gender | |
| Male | 68 (54.8) |
| Female | 56 (45.2) |
| Age, years | |
| Mean | 45.1 |
| SD | 16.5 |
| WHO grade | |
| I/II | 79 (63.7) |
| III/IV | 45 (36.3) |
| Pathological diagnosis | 16.5 |
| DA | 96 (77.4) |
| OL | 6 (4.8) |
| AOA | 1 (0.8) |
| GBM | 12 (9.7) |
| EP | 9 (7) |
| Recurrence | |
| No | 30 (24.2) |
| Yes | 94 (75.8) |
| Radiotherapy | |
| No | 48 (38.7) |
| Yes | 76 (61.3) |
| Chemotherapy | |
| No | 74 (59.7) |
| Yes | 50 (40.3) |
| Seizures | |
| No | 68 (54.8) |
| Yes | 56 (45.2) |
| KPS | |
| ≤ 80 | 76 (61.3) |
| > 80 | 48 (38.7) |
| Smoking history | |
| No | 89 (71.8) |
| Yes | 35 (28.2) |
| Survival status | |
| Dead | 45 (41.1) |
| Alive | 73 (58.9) |
Abbreviations: Diffuseastrocytoma (DA); Oligodendroglioma (OL); Anaplastic oligoastrocytoma (AOA); Glioblastoma (GBM); Ependymoma (EP); Karnofsky performance status (KPS).